114 related articles for article (PubMed ID: 38672528)
41. Feasibility of combining oncology surgery with bariatric surgery; a two-patient case series of sleeve gastrectomy with cytoreductive surgery and HIPEC.
Aburahmah M; Hijji TM; Saif LT; Kalagi D; Azzam AZ; Amin T
J Surg Case Rep; 2022 Jan; 2022(1):rjab588. PubMed ID: 35047173
[TBL] [Abstract][Full Text] [Related]
42. Peritoneal surface malignancy spread reoperations after cytoreductive surgery + HIPEC.
Antoš F; Bartoška P; Vobořil R
Rozhl Chir; 2021; 100(10):469-474. PubMed ID: 35021837
[TBL] [Abstract][Full Text] [Related]
43. Peritoneal metastases found in routinely resected specimens after cytoreductive surgery and heated intraperitoneal chemotherapy.
Nors J; Iversen LH; Nielsen K; Sørensen MM; Verwaal VJ; Funder JA
Eur J Surg Oncol; 2022 Apr; 48(4):795-802. PubMed ID: 35012833
[TBL] [Abstract][Full Text] [Related]
44. A case of Pseudomyxoma Peritonei of an unexpected origin.
Csanyi-Bastien M; Blanchard F; Lamy A; Sabourin JC
Diagn Pathol; 2021 Dec; 16(1):119. PubMed ID: 34930348
[TBL] [Abstract][Full Text] [Related]
45. The many faces of intraperitoneal chemotherapy.
Abdel Mageed H; Van Der Speeten K; Sugarbaker P
Surg Oncol; 2022 Mar; 40():101676. PubMed ID: 34875459
[TBL] [Abstract][Full Text] [Related]
46. Peritoneal disease: key imaging findings that help in the differential diagnosis.
Campos NMF; Almeida V; Curvo Semedo L
Br J Radiol; 2022 Feb; 95(1130):20210346. PubMed ID: 34767464
[TBL] [Abstract][Full Text] [Related]
47. Pseudomyxoma peritonei of appendiceal origin mimicking ovarian cancer - a case report with literature review.
Kostov S; Kornovski Y; Slavchev S; Ivanova Y; Dzhenkov D; Yordanov A; Slavcheva S
Prz Menopauzalny; 2021 Sep; 20(3):148-153. PubMed ID: 34703416
[TBL] [Abstract][Full Text] [Related]
48. Blood Flow and Shear Stress Allow Monitoring of Progression and Prognosis of Tumor Diseases.
Barral M; El-Sanharawi I; Dohan A; Sebuhyan M; Guedon A; Delarue A; Boutigny A; Mohamedi N; Magnan B; Kemel S; Ketfi C; Kubis N; Bisdorff-Bresson A; Pocard M; Bonnin P
Front Physiol; 2021; 12():693052. PubMed ID: 34413786
[TBL] [Abstract][Full Text] [Related]
49. Time to Evolve Terminology from "Debulking" to Cytoreductive Surgery (CRS) in Ovarian Cancer.
Brennan DJ; Moran BJ
Ann Surg Oncol; 2021 Oct; 28(11):5805-5807. PubMed ID: 34304313
[No Abstract] [Full Text] [Related]
50. Debulking surgery for malignant tumors: the current status, evidence and future perspectives.
Hishida T; Masai K; Kaseda K; Asakura K; Asamura H
Jpn J Clin Oncol; 2021 Aug; 51(9):1349-1362. PubMed ID: 34254145
[TBL] [Abstract][Full Text] [Related]
51. First Report of a Low-Grade Pseudomyxoma peritonei Originating from Gall Bladder.
Prabhu A; Brandl A; Wakama S; Sako S; Ishibashi H; Nishino E; Yonemura Y
Visc Med; 2021 Jun; 37(3):222-225. PubMed ID: 34250081
[TBL] [Abstract][Full Text] [Related]
52. A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei.
Arjona-Sánchez Á; Martínez-López A; Valenzuela-Molina F; Rufián-Andújar B; Rufián-Peña S; Casado-Adam Á; Sánchez-Hidalgo JM; Rodríguez-Ortiz L; Medina-Fernández FJ; Díaz-López C; Granados-Rodríguez M; Ortega-Salas R; Castaño JP; Tena-Sempere M; Briceño-Delgado J; Romero-Ruíz A
Ann Surg Oncol; 2022 Jan; 29(1):126-136. PubMed ID: 34215955
[TBL] [Abstract][Full Text] [Related]
53. Development of stress-induced cardiomyopathy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Naved SA; Parpia SS; Ali HS
J Pak Med Assoc; 2021 Jun; 71(6):1686-1688. PubMed ID: 34111099
[TBL] [Abstract][Full Text] [Related]
54. Feasibility and outcomes of cytoreductive surgery and HIPEC for peritoneal surface malignancies in low- and middle-income countries: a single-center experience of 232 cases.
Deo S; Ray M; Bansal B; Bhoriwal S; Bhatnagar S; Garg R; Gupta N; Sharma A; Kumar L; Thulkar S; Dhamija E; Mathur S; Das P
World J Surg Oncol; 2021 Jun; 19(1):164. PubMed ID: 34090452
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological Characteristics and Prognostic Prediction in Pseudomyxoma Peritonei Originating From Mucinous Ovarian Cancer.
Fu F; Ma X; Lu Y; Xu H; Ma R
Front Oncol; 2021; 11():641053. PubMed ID: 33968739
[TBL] [Abstract][Full Text] [Related]
56. Mid-Term Audit of a National Peritoneal Surface Malignancy Program Implementation in a Low Middle Income Country: The Moroccan Experience.
Souadka A; Essangri H; Majbar MA; Benkabbou A; Boutayeb S; Amrani L; Ghannam A; El Ahmadi B; Belkhadir ZH; Mohsine R; Souadka A; Elias D
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802609
[TBL] [Abstract][Full Text] [Related]
57. Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics.
Dundr P; Singh N; Nožičková B; Němejcová K; Bártů M; Stružinská I
Diagn Pathol; 2021 Mar; 16(1):20. PubMed ID: 33706757
[TBL] [Abstract][Full Text] [Related]
58. A general overview of mucocele of appendix.
Singh MP
J Family Med Prim Care; 2020 Dec; 9(12):5867-5871. PubMed ID: 33681010
[TBL] [Abstract][Full Text] [Related]
59. Huge and Unique Pseudomyxoma Peritonei.
Tjokroprawiro BA; Nugroho H; Indraprasta BR
J Obstet Gynaecol India; 2022 Jun; 72(3):268-269. PubMed ID: 33679016
[No Abstract] [Full Text] [Related]
60. A case of Endometrioid endometrial adenocarcinoma with synchronous low-grade Appendiceal mucinous neoplasm and Pseudomyxoma peritonei.
Raje S; Arvind S; Rao G
J Minim Access Surg; 2021; 17(3):418-420. PubMed ID: 33605928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
